InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the full record of transactions filed by Berger Dietmar. Officer active across 1 company, notably Gilead Sciences, INC.. Aggregated, 5 reports have been recorded. History available since 27 February 2026. The latest transaction was filed on 27 February 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Berger Dietmar is a declarant linked to Gilead Sciences, INC., where the listed role is Chief Medical Officer. The record shows 5 filings in total, with 5 sampled filings between 2026-01-05 and 2026-06-11, and the most common transaction nature is option exercise.